Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows

NCT00752050 ↗

Phase 3 Completed 699 enrolled Mentor Worldwide, LLC Synteract, Inc. · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The overall purpose of this study is to evaluate the safety and effectiveness of repeat treatment of an intramuscular dose of Mentor Purified Toxin for the reduction of frown lines, compared with placebo.

Timeline

Start: 2007-11
Primary completion: 2009-02
Completion: 2009-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Mentor Purified Toxin	Unknown	30 iu	Intramuscular

Indications

No indication recorded.